VPIM
Vanguard Personalized Indexing Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
149,916
+22,191
| +17% | +$1.53M | 0.12% | 149 |
|
|
2025
Q1 | $8.87M | Buy |
127,725
+16,567
| +15% | +$1.15M | 0.13% | 136 |
|
|
2024
Q4 | $9.56M | Sell |
111,158
-12,316
| -10% | -$1.06M | 0.14% | 105 |
|
|
2024
Q3 | $14.7M | Buy |
123,474
+8,988
| +8% | +$1.07M | 0.24% | 68 |
|
|
2024
Q2 | $16M | Buy |
114,486
+13,288
| +13% | +$1.86M | 0.31% | 46 |
|
|
2024
Q1 | $13M | Buy |
101,198
+11,891
| +13% | +$1.53M | 0.28% | 58 |
|
|
2023
Q4 | $9.24M | Buy |
89,307
+335
| +0.4% | +$34.7K | 0.24% | 67 |
|
|
2023
Q3 | $8.09M | Buy |
88,972
+48,222
| +118% | +$680K | 0.24% | 63 |
|
|
2023
Q2 | $6.59M | Buy |
40,750
+3,082
| +8% | +$499K | 0.2% | 84 |
|
|
2023
Q1 | $5.98M | Buy |
37,668
+2,337
| +7% | +$371K | 0.21% | 86 |
|
|
2022
Q4 | $4.78M | Buy |
35,331
+4,317
| +14% | +$584K | 0.2% | 94 |
|
|
2022
Q3 | $3.09M | Buy |
31,014
+267
| +0.9% | +$26.6K | 0.14% | 136 |
|
|
2022
Q2 | $3.43M | Buy |
30,747
+8,648
| +39% | +$964K | 0.16% | 114 |
|
|
2022
Q1 | $2.45M | Buy |
22,099
+4,247
| +24% | +$471K | 0.12% | 156 |
|
|
2021
Q4 | $2M | Buy |
17,852
+3,691
| +26% | +$413K | 0.12% | 165 |
|
|
2021
Q3 | $1.36M | Buy |
14,161
+2,343
| +20% | +$225K | 0.12% | 163 |
|
|
2021
Q2 | $990K | Sell |
11,818
-12,875
| -52% | -$1.08M | 0.1% | 208 |
|
|
2021
Q1 | $1.67M | Sell |
24,693
-104
| -0.4% | -$7.01K | 0.25% | 81 |
|
|
2020
Q4 | $1.73M | Buy |
24,797
+967
| +4% | +$67.5K | 0.38% | 53 |
|
|
2020
Q3 | $1.66M | Buy |
23,830
+3,504
| +17% | +$243K | 0.46% | 47 |
|
|
2020
Q2 | $1.33M | Sell |
20,326
-1,112
| -5% | -$72.8K | 0.6% | 35 |
|
|
2020
Q1 | $1.29M | Buy |
+21,438
| New | +$1.29M | 0.75% | 28 |
|